American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…
Read More »Drugs
Beijing’s new rules for state-led bulk tendering of medical drugs are the latest example of its “anti-involution” drive to combat…
Read More »
China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…
Read More »
Chinese tech giant Baidu is in talks with investors to raise up to US$2 billion over three years for a…
Read More »
The dietary supplement producer, established in 2004, spent 2 billion yuan (US$294 million) to build a factory this year in…
Read More »
Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »
Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…
Read More »
A new study has pinpointed brain neurons that separate the sensation of fullness from nausea in obesity drugs, paving the…
Read More »
Research on MDMA’s use in psychotherapy have led to new variants developed by MedUni Vienna that could offer similar benefits…
Read More »
Researchers have found that studying proteins at body temperature reveals new drug binding sites, potentially revolutionizing drug design by providing…
Read More »